
AptarGroup, Inc.
ATRNYSEHealthcareMedical - Instruments & Supplies
Previous close
$134.8
+$1.84 · +1.38%
ATR company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Buy
Favorable setup — positive multi-factor alignment
Valuation
85
Deep Value
Momentum
42
Neutral
Sentiment
60
Mixed
Risk resilience
75
Moderate Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteAptarGroup, Inc. specializes in developing and manufacturing solutions for dispensing, sealing, and advanced material science, catering to a broad spectrum of industries such as beauty, personal care, home care, and the pharmaceutical sector (including prescription drugs, consumer health care, and injectables), alongside the food and beverage markets. Its operations are structured into three key segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma division offers critical components for the pharmaceutical industry, including pumps for nasal allergy remedies, metered dose inhaler valves vital for managing respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), elastomeric primary packaging for injectables, and sophisticated active material science innovations. The Beauty + Home segment primarily supplies the personal care and home care sectors with essential products such as pumps, various closures, aerosol valves, accompanying accessories, and sealing mechanisms. It also furnishes the beauty market with pumps and decorative elements. For the food and beverage industries, its Food + Beverage segment delivers a variety of dispensing and non-dispensing closures, specialized elastomeric flow control components, spray pumps, and aerosol valves. AptarGroup markets its offerings globally, utilizing its internal sales team, complemented by independent representatives and distributors across Asia, Europe, Latin America, and North America. The company is engaged in a strategic partnership with PureCycle Technologies LLC to pioneer the integration of ultra-pure recycled polypropylene into advanced dispensing applications. Additionally, it collaborates with Sonmol on the development of a digital platform providing therapies and services, with a particular focus on respiratory and other health conditions. Established in 1992, AptarGroup, Inc. maintains its corporate headquarters in Crystal Lake, Illinois.
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Stephan Tanda
- Listed since
- Apr 23, 1993
- Employees
- 14,000
Market position
Day range
Current $134.8
52-week range
Current $134.8
- Open
- $134.12
- Previous close
- $132.96
- Volume
- 225.82K
- 0.45× average
- Average volume
- 498.37K
- Average daily volume
- Market cap
- 8.6B USD
- Beta
- 0.38
- Market reference 1
- 50-day average
- $128.94
- +4.55% above average
- 200-day average
- $125.79
- +7.16% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 9.15B USD
- EV / EBITDA
- 11×
- Earnings yield
- 4.90%
- Free cash flow yield
- 3.74%
Profitability & efficiency
- Return on equity
- 14.72%
- Return on assets
- 7.48%
- Return on invested capital
- 9.24%
Financial health
- Current ratio
- 1.62×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.78B USD | 3.58B USD | 3.49B USD | 3.32B USD | 3.23B USD |
| Cost of goods sold | 2.66B USD | 2.23B USD | 2.22B USD | 2.16B USD | 2.07B USD |
| Gross profit | 1.12B USD | 1.36B USD | 1.26B USD | 1.16B USD | 1.16B USD |
| Research and development | 105.1M USD | — | — | — | 99.8M USD |
| Selling, general, and administrative | 499.94M USD | 582.23M USD | 565.78M USD | 544.26M USD | 551.24M USD |
| Operating expenses | 605.04M USD | 859.01M USD | 859.38M USD | 784.57M USD | 809.34M USD |
| Interest income | 11.68M USD | 12.1M USD | 4.37M USD | 2.7M USD | 3.67M USD |
| Interest expense | 52.74M USD | 43.9M USD | 40.42M USD | 40.83M USD | 30.28M USD |
| Depreciation and amortization | 287.36M USD | 263.78M USD | 248.59M USD | 233.71M USD | 234.85M USD |
| Operating income | 512.34M USD | 496.5M USD | 404.02M USD | 379.27M USD | 347.35M USD |
| Net income | 392.79M USD | 374.54M USD | 284.49M USD | 239.29M USD | 244.1M USD |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 100%
- 11 beats, 0 misses, 0 met estimates
- Average EPS surprise
- +5.74%
- 11 comparable reports
- Latest EPS result
- 1.42
- Estimate 1.35 · Beat by 5.19%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Analyst price target
Average target
$160
18.69% upsidePrice history unavailable
High $160Average $160Low $160ATR news
Corporate actions
Annual dividends per share
Cash distributions grouped by calendar year; partial years are marked.
$1.83
2025 complete year+22.0% since 2021
2026 partial: $1.44
$1.50
2,021
$1.52
2,022
$1.58
2,023
$1.72
2,024
$1.83
2,025
$1.44
2,026*
* Partial calendar year in the available dividend history.
Corporate action history
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Jul 30, 2026 | $0.48Quarterly | Jul 30, 2026 | Aug 20, 2026 |
Dividend | May 6, 2026 | $0.48Quarterly | May 6, 2026 | May 27, 2026 |
Dividend | Feb 4, 2026 | $0.48Quarterly | Feb 4, 2026 | Feb 25, 2026 |
Dividend | Oct 23, 2025 | $0.48Quarterly | Oct 23, 2025 | Nov 13, 2025 |
Dividend | Jul 24, 2025 | $0.45Quarterly | Jul 24, 2025 | Aug 14, 2025 |
Dividend | May 1, 2025 | $0.45Quarterly | May 1, 2025 | May 22, 2025 |
Ex-dividend Jul 30, 2026
$0.48
Quarterly
Record Jul 30, 2026 · Payment Aug 20, 2026
Ex-dividend May 6, 2026
$0.48
Quarterly
Record May 6, 2026 · Payment May 27, 2026
Ex-dividend Feb 4, 2026
$0.48
Quarterly
Record Feb 4, 2026 · Payment Feb 25, 2026
Ex-dividend Oct 23, 2025
$0.48
Quarterly
Record Oct 23, 2025 · Payment Nov 13, 2025
Ex-dividend Jul 24, 2025
$0.45
Quarterly
Record Jul 24, 2025 · Payment Aug 14, 2025
Ex-dividend May 1, 2025
$0.45
Quarterly
Record May 1, 2025 · Payment May 22, 2025
ATR peers
ETFs holding ATR
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core S&P Mid-Cap ETFIJH290.8M0.23%125.92B USD0.05%$76.77+0.52%
Vanguard Morningstar Total Stock Market ETFVTI272.27M0.01%2.3T USD0.03%$378.24+0.44%
Vanguard Morningstar Small-Cap ETFVB196.59M0.11%183.4B USD0.03%$304.76+0.64%
Vanguard Morningstar Small-Cap Value ETFVBR124.83M0.18%68.3B USD0.05%$249.18+0.68%
Vanguard Extended Market ETFVXF98.54M0.10%93.7B USD0.05%$245.53+0.82%
State Street SPDR S&P Dividend ETFSDY75.51M0.34%22.07B USD0.35%$158.44+0.23%
State Street SPDR S&P MIDCAP 400 ETF TrustMDY62.14M0.23%26.72B USD0.23%$699.6+0.48%
Vanguard Dividend Appreciation ETFVIG48.37M0.04%130.9B USD0.04%$243.91+0.69%
iShares Core S&P Mid-Cap ETFIJH- Market value
- 290.8M
- Weight
- 0.23%
- AUM
- 125.92B USD
- Expense ratio
- 0.05%
- Price / 1D
- $76.77+0.52%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 272.27M
- Weight
- 0.01%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
Vanguard Morningstar Small-Cap ETFVB- Market value
- 196.59M
- Weight
- 0.11%
- AUM
- 183.4B USD
- Expense ratio
- 0.03%
- Price / 1D
- $304.76+0.64%
Vanguard Morningstar Small-Cap Value ETFVBR- Market value
- 124.83M
- Weight
- 0.18%
- AUM
- 68.3B USD
- Expense ratio
- 0.05%
- Price / 1D
- $249.18+0.68%
Vanguard Extended Market ETFVXF- Market value
- 98.54M
- Weight
- 0.10%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $245.53+0.82%
State Street SPDR S&P Dividend ETFSDY- Market value
- 75.51M
- Weight
- 0.34%
- AUM
- 22.07B USD
- Expense ratio
- 0.35%
- Price / 1D
- $158.44+0.23%
State Street SPDR S&P MIDCAP 400 ETF TrustMDY- Market value
- 62.14M
- Weight
- 0.23%
- AUM
- 26.72B USD
- Expense ratio
- 0.23%
- Price / 1D
- $699.6+0.48%
Vanguard Dividend Appreciation ETFVIG- Market value
- 48.37M
- Weight
- 0.04%
- AUM
- 130.9B USD
- Expense ratio
- 0.04%
- Price / 1D
- $243.91+0.69%
Continue in GoAI
Research ATRresearch.disclaimer











